New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
Philadelphia-negative myeloproliferative neoplasms (MPN) are aggressive diseases characterized by clonal proliferation of myeloid stem cells. The clonal process leads to excessive red cells production, platelets production, and bone marrow fibrosis. According to the phenotype, MPN can be classified...
Guardado en:
Autor principal: | Domenico Penna |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/61c8db4b2543475f9aad70a2daa5087c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
por: Vaddi K, et al.
Publicado: (2016) -
Disseminated tuberculosis with myelofibrosis presentation: a case report
por: Mahdi Khatuni, et al.
Publicado: (2021) -
Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
por: Magdalena M. Brune, et al.
Publicado: (2021) -
Polycythemia Vera (PV): Update on Emerging Treatment Options
por: Benevolo G, et al.
Publicado: (2021) -
The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
por: Marco Pizzi, et al.
Publicado: (2021)